共 59 条
[1]
Pillai S(2016)Updates on the genetics and the clinical impacts on phaeochromocytoma and paraganglioma in the new era Crit Rev Oncol Hematol 100 190-208
[2]
Gopalan V(2001)Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma Am J Hum Genet 69 49-54
[3]
Smith RA(2014)Current approaches and recent developments in the management of head and neck paragangliomas Endocr Rev 35 795-819
[4]
Astuti D(2009)The approach to the patient with paraganglioma J Clin Endocrinol Metab 94 2677-2683
[5]
Latif F(2008)Clinical manifestations of familial paraganglioma and phaeochromocytomas in succinate dehydrogenase B (SDH-B) gene mutation carriers Clin Endocrinol (Oxf) 69 587-596
[6]
Dallol A(2006)Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes J Clin Endocrinol Metab 91 827-836
[7]
Taieb D(2012)Pheochromocytoma and paraganglioma: understanding the complexities of the genetic background Cancer Genet 205 1-11
[8]
Kaliski A(2010)Are we overestimating the penetrance of mutations in SDHB? Hum Mutat 31 761-762
[9]
Boedeker CC(2009)Penetrance and clinical consequences of a gross SDHB deletion in a large family Clin Genet 75 354-363
[10]
Neumann HP(2010)Tumor risks and genotype-phenotype-proteotype analysis in 358 patients with germline mutations in SDHB and SDHD Hum Mutat 31 41-51